Pneumococcal infections: cases due to serotypes covered by Prevenar 7
Updated 24 September 2014
Cumulative weekly number of reports of invasive pneumococcal disease due to any of the seven serotypes in Prevenar 7™ : children under 2 in England and Wales by epidemiological year: from July to June (from 2005 to now)
Cumulative weekly number of reports of invasive pneumococcal disease due to any of the seven serotypes in Prevenar 7™ : children 2 to 4 in England and Wales by epidemiological year: from July to June (from 2005 to now)
Cumulative weekly number of reports of invasive pneumococcal disease due to any of the seven serotypes in Prevenar 7™ : those aged 5 or older in England and Wales by epidemiological year: from July to June (from 2005 to now)
Source: Immunisation Department, Public Health England (PHE)
The graphs are based on week of isolation so numbers for the most recent weeks may not be complete. Number of reports of serotyped cases shown in the graphs are not adjusted to account for any change that may have occurred over time and between age groups in the proportion of all invasive pneumococcal disease cases that are serotyped.
The 7-valent conjugate vaccine was introduced into the childhood immunisation schedule on 4 September 2006, which corresponds with week 36 in the graphs.
The 13-valent conjugate vaccine was introduced into the childhood immunisation schedule on the 1 April 2010, which corresponds with week 13 in the graphs.